Bristol Myers Squibb (BMY) Income After Tax (2009 - 2026)
Bristol Myers Squibb's Income After Tax came in at $2.16 billion for Q3 2026, down 1.5% from $2.2 billion a year earlier and down 34.8% from the prior quarter.
Bristol Myers Squibb (BMY) Income After Tax (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Bristol Myers Squibb reported Income After Tax of $9.24 billion, up 52.9% year-over-year; for FY2025, it came in at $7.06 billion.
- Going back by year, Income After Tax was -$8.93 billion in FY2024, $8.04 billion in FY2023 (+26.7%), $6.35 billion in FY2022 (-9.5%) and $7.01 billion in FY2021.
- The five-year range for quarterly Income After Tax is -$11.91 billion (Q1 2024) to $3.32 billion (Q2 2026).
- Year-over-year, Income After Tax increased in three of the last six quarters, with growth averaging 20.5%.
- The fastest year-over-year change in Income After Tax over five years came in Q2 2026 (growth of 152.6%), and the weakest in Q4 2024 (a decline of 95.7%).
- Business Quant data shows BMY's Income After Tax at $3.32 billion (Q2 2026), $2.68 billion (Q1 2026) and $1.09 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Bristol Myers Squibb | 128.63 Bn | 83.82 Bn | 8.92 Bn | 2.16 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.16 Bn |
| Jun 30, 2026 | 3.32 Bn |
| Mar 31, 2026 | 2.68 Bn |
| Dec 31, 2025 | 1.09 Bn |
| Sep 30, 2025 | 2.20 Bn |
| Jun 30, 2025 | 1.31 Bn |
| Mar 31, 2025 | 2.46 Bn |
| Dec 31, 2024 | 76.00 Mn |
| Sep 30, 2024 | 1.22 Bn |
| Jun 30, 2024 | 1.68 Bn |
| Mar 31, 2024 | -11.91 Bn |
| Dec 31, 2023 | 1.76 Bn |
| Sep 30, 2023 | 1.93 Bn |
| Jun 30, 2023 | 2.08 Bn |
| Mar 31, 2023 | 2.27 Bn |
| Dec 31, 2022 | 2.03 Bn |
| Sep 30, 2022 | 1.61 Bn |
| Jun 30, 2022 | 1.43 Bn |
| Mar 31, 2022 | 1.28 Bn |
| Dec 31, 2021 | 2.37 Bn |
Bristol Myers Squibb Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();